Financials
- Financial year
- 2025
- Total assets
- €228,047
- Profit
- €9,393
- Solvency
- 15.5%
Total assets▼ 8.7%
Net result
20182025
APOTHEEK WINTERS BEA
ActiveSummary
APOTHEEK WINTERS BEA has been active since 2003 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €35,433 and a net result of €9,393. Equity is shrinking by about 11% per year across the filed financial years. Its solvency ranks better than 26% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€228,047total assets 2025
- Staff
- 1 FTE
- Equity
- €35,433
- Profit
- €9,393
Turnover not published (abbreviated format)
Structure
2025 accounts 42 days early2 deeds in the Belgian Official Gazette
Why 70raises riskEquity €35,433 (15.5% of total assets)1 of the last 3 latelowers riskFounded in 2003Liquidity: current ratio 1.13, cash €49,650Show the evidence
Checked score
Score 2025
70
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 44% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency
41+6
equity 15.5% of total assets
Liquidity
31=
short-term debt 83.5% · cash 21.8%
Profitability
46-44
return on assets 4.1%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 4.4%highest value
12-2024: 4.4%● unchanged vs 11-2024highest value
01-2025: 4.4%● unchanged vs 12-2024
02-2025: 4.4%● unchanged vs 01-2025
03-2025: 4.4%● unchanged vs 02-2025
04-2025: 4.3%▼ -0.1 percentage points vs 03-2025
05-2025: 4.3%● unchanged vs 04-2025
06-2025: 0.7%▼ -3.6 percentage points vs 05-2025
07-2025: 0.7%● unchanged vs 06-2025
08-2025: 0.7%● unchanged vs 07-2025
09-2025: 0.7%● unchanged vs 08-2025
10-2025: 0.7%● unchanged vs 09-2025
11-2025: 0.7%● unchanged vs 10-2025
12-2025: 0.7%● unchanged vs 11-2025
01-2026: 0.7%● unchanged vs 12-2025
02-2026: 0.7%● unchanged vs 01-2026
03-2026: 0.7%● unchanged vs 02-2026
04-2026: 0.7%● unchanged vs 03-2026
05-2026: 0.7%● unchanged vs 04-2026
06-2026: 0.6%▼ -0.1 percentage points vs 05-2026
07-2026: 0.6%● unchanged vs 06-2026
08-2026: 0.9%▲ +0.3 percentage points vs 07-2026
09-2026: 1.1%▲ +0.2 percentage points vs 08-2026
10-2026: 0.6%▼ -0.5 percentage points vs 09-2026lowest value
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.13, compared with 1.08 in 2024, below the usual 1.5; short-term debt: 83.5% and cash: 21.8% of total assets), and 84.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 32% on solvency, 28% on liquidity, 34% on profitability and 82% on growth.
The bankruptcy probability was computed on 27-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 19-06-2026, 42 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
42 days early
2024
77 days early
2023
57 days late
2022
30 days late
2021
30 days late
2020
30 days late
2019
122 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 21 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 filed years within 72 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · abbreviated…
- Back to profitnet €42,300
Key points
By topic
Timeline
- Events
- 26
- Since
- 2005
- Next accounts
- by 31-07-2027
- 26-09-2024Annual accounts filed
- 31-12-2023Weakest financial year
- 30-08-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company (pre-2019)
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 24-07-2003
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about APOTHEEK WINTERS BEA
- What is the company number of APOTHEEK WINTERS BEA?
- 0859.755.045. In Belgium the VAT number is the company number with BE in front: BE 0859.755.045.
- Where is APOTHEEK WINTERS BEA based?
- The registered office is at Pieter Breugellaan 17, 3990 Peer.Company details
- What does APOTHEEK WINTERS BEA do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK WINTERS BEA?
- Private limited company (pre-2019) (BVBA).
- When was APOTHEEK WINTERS BEA founded?
- On 24-07-2003.
- Is APOTHEEK WINTERS BEA still active?
- Yes, APOTHEEK WINTERS BEA is an active enterprise in the KBO register.
- How many employees does APOTHEEK WINTERS BEA have?
- On average 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of APOTHEEK WINTERS BEA?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is APOTHEEK WINTERS BEA profitable?
- In financial year 2025, APOTHEEK WINTERS BEA made a profit of €9,393.
- Where can I find the annual accounts of APOTHEEK WINTERS BEA?
- APOTHEEK WINTERS BEA filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK WINTERS BEA due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to APOTHEEK WINTERS BEA
Comparable companies
- ESPACE MEDICAL JUMETCharleroi
- Elisabeth in ’t VeldHolsbeek
- APOTHEEK VAN HOECKEKortrijk
- PHARMACIE HERMAN GEOFFREYAndenne
- Apotheek ParichaZelzate
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.